Embodiments of the disclosure concern methods and compositions for enhancing therapy for a medical condition, such as cancer. In particular embodiments, the therapy comprises cellular therapy, and the disclosure concerns manipulation of the cells to release contents of lytic granules in a diffuse manner to promote killing of nearby cells in dispersed directions. In specific cases, the disclosure concerns exposing the cells to an inhibitor of granule transport molecules, such as dynein, for example.